Aktiesnakken — April 2010
-
sensodyne er den hurtigst voksende tandpasta i US
-
intet nyt om arzerra, men tykerb er nævnt men 62% vækst
-
dermatologist skal gøres global
-
stiefl skal til india,china og japan
-
synergierne er på vej og på sporet og leverer 2,2 mia pund i 2011
-
sales growth
-
så kom Arzerra godkendelsen!
-
continue to see progress in approval
-
30 major programs in phase 3 hele tiden
-
2,2 billion costsaving i 2012
-
investerer i growth businesses
-
advokatomkostninger ! er oppe
-
det koster 450 mill pund i advokater hvert år gennemsnitlig
-
progressive dividend policy
-
stinker, apropos landbrug/banker http://borsen.dk/finans/nyhed/181957/
-
delivers sustained performance
-
Det var så Andrew
-
nu kommer Julian
-
masser af pandemic salg
-
her er deres q1 report http://www.gsk.com/investors/reports/q12010/q12010.pdf
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind